The invention describes the use of commercial analogs of ATP, with substitutions of methylene, L- beta gamma - methylene adenosine 5'-triphosphate, imide, D- beta gamma -imide adenosine 5'-triphosphate and the natural substance adenosine 5' tetraphosphate Ap4, in the treatment of glaucoma and ocular hypertension.